German Specialty Pharma Firm Riemser Arzneimittel Bought By AXA Private Equity
This article was originally published in The Pink Sheet Daily
Executive Summary
AXA Private Equity's acquisition of Riemser Arzneimittel is the third change of ownership in the European specialty pharmaceuticals and manufacturing sectors this month, with more likely to follow as buyout specialists seeks the right combination of companies for consolidation.